Comparative analysis of Peg-Interferon alpha-2b and Lamivudine in the treatment of chronic hepatitis B patients: Preliminary results

被引：1
|
作者：
Koliouskas, D [1 ]
Sidiropoulos, I [1 ]
Masmanidou, M [1 ]
Dokas, S [1 ]
Ziakas, A [1 ]
机构：
[1] AHEPA Gen Hosp, Thessaloniki, Greece
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80852-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
851
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [41] Peg-interferon lambda Treatment induces robust innate and adaptive immunity in chronic hepatitis B Patients
    Phillips, Sandra
    Mistry, Sameer
    Riva, Antonio
    Cooksley, Helen
    Hadzhiolova-Lebeau, Tanya
    Plavova, Slava
    Katzarov, Krum
    Simonova, Marieta
    Zeuzem, Stephan
    Woffendin, Clive
    Chen, Pei-Jer
    Peng, Cheng-Yuan
    Chang, Ting-Tsung
    Lueth, Stefan
    De Knegt, Robert
    Choi, Moon-Seok
    Wedemeyer, Heiner
    Dao, Michael
    Kim, Chang-Wook
    Chu, Heng-Chen
    Wind-Rotolo, Megan
    Williams, Roger
    Cooney, Elizabeth
    Chokshi, Shilpa
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [42] Successful treatment of acute hepatitis C with alpha 2b Peg-interferon monotherapy: An interim analysis.
    Santantonio, T
    Sinisi, E
    Signorile, F
    Guastadisegni, A
    Casalino, C
    Mazzola, M
    Francavilla, R
    Pastore, G
    HEPATOLOGY, 2003, 38 (04) : 642A - 642A
  • [43] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Mukherjee, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03): : 727 - 727
  • [44] Peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive Egyptian patients
    El-Wakil, R. M.
    Montasser, M. F.
    Mansour, M. A.
    Salman, T. A.
    EL-Batanony, M. H.
    Helail, E. H.
    Shehata, K. O.
    Attallah, K. M.
    Madwar, M. A.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S142 - S143
  • [45] Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT
    Jacobson, IM
    Ahmed, F
    Russo, MW
    Lebovics, E
    Dieterich, DI
    Esposito, SP
    Bach, N
    Klion, F
    Tobias, H
    Antignano, L
    Brown, RS
    Gabbaizadeh, D
    Geders, J
    Levendoglu, H
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1700 - 1705
  • [46] Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine
    van Zonneveld, M
    Zondervan, PE
    Cakaloglu, Y
    Simon, C
    Akarca, US
    So, TMK
    Flink, HJ
    de Man, RA
    Schalm, SW
    Janssen, HLA
    LIVER INTERNATIONAL, 2006, 26 (04) : 399 - 405
  • [47] Treatment with pegylated-interferon alpha-2b (Peg-Interferon) plus ribavirin in relapsers to standard interferon plus ribavirin in chronic hepatitis C : Efficacy and safety results from a randomized multicentric french study.
    Portal, I
    Botta-Fridlund, D
    Bourliere, M
    Couzigou, P
    Barange, K
    Canva, V
    Larrey, D
    Rotily, M
    Halfon, P
    HEPATOLOGY, 2002, 36 (04) : 359A - 359A
  • [48] Acute hepatitis-C - Treatment with interferon alpha-2b
    Thimme, R
    Blum, HE
    INTERNIST, 2002, 43 (09): : 1148 - 1150
  • [49] A CLINICAL STUDY ON EFFICACY OF INTERFERON ALPHA-2B PLUS HEPATITIS B GRANULE NO. 3 FOR THE TREATMENT OF CHRONIC HEPATITIS B
    He, J.
    Zhou, D.
    Gao, H.
    Tong, G.
    Zhou, X.
    Zhan, B.
    Xing, Y.
    Chen, Y.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S330 - S330
  • [50] Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial
    Schalm, SW
    Heathcote, J
    Cianciara, J
    Farrell, G
    Sherman, M
    Willems, B
    Dhillon, A
    Moorat, A
    Barber, J
    Gray, DF
    GUT, 2000, 46 (04) : 562 - 568
12345